Literature DB >> 18778868

MicroRNA target site polymorphisms and human disease.

Praveen Sethupathy1, Francis S Collins.   

Abstract

MicroRNAs (miRNAs) are important regulators of eukaryotic gene expression. They have been implicated in a broad range of biological processes, and miRNA-related genetic alterations probably underlie more human diseases than currently appreciated. Several studies have identified genetic variants in miRNA target sites that are claimed to be associated with disorders ranging from Parkinson's disease to cancer. However, careful assessment of these studies indicates that very few provide a combination of rigorous genetic and functional evidence. We therefore suggest a set of concrete recommendations to guide future investigations. Specifically, we highlight the importance of unbiased association studies and follow-up functional experiments for providing a clearer picture of the extent to which microRNA target site variations are relevant in various human diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778868     DOI: 10.1016/j.tig.2008.07.004

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  145 in total

1.  Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

Authors:  Kuixing Zhang; Saiful A Mir; C Makena Hightower; Jose Pablo Miramontes-Gonzalez; Adam X Maihofer; Yuqing Chen; Sushil K Mahata; Caroline M Nievergelt; Nicholas J Schork; Barry I Freedman; Sucheta M Vaingankar; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 10.121

Review 2.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

Review 3.  MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Authors:  Rachel C Blitzblau; Joanne B Weidhaas
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

Review 4.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

5.  Demonstrating polymorphic miRNA-mediated gene regulation in vivo: application to the g+6223G->A mutation of Texel sheep.

Authors:  Haruko Takeda; Carole Charlier; Frédéric Farnir; Michel Georges
Journal:  RNA       Date:  2010-08-02       Impact factor: 4.942

6.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

7.  MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia.

Authors:  Kasey C Vickers; Bassem M Shoucri; Michael G Levin; Han Wu; Daniel S Pearson; David Osei-Hwedieh; Francis S Collins; Alan T Remaley; Praveen Sethupathy
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

Review 8.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

Review 9.  The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.

Authors:  Gianluca Serafini; Maurizio Pompili; Katelin F Hansen; Karl Obrietan; Yogesh Dwivedi; Noam Shomron; Paolo Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

Review 10.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.

Authors:  Prasun J Mishra; Joseph R Bertino
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.